Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 252 participants.

Also called NCT04754659

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 252 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04754659
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04754659. Randomized; triple masking; primary purpose treatment. Start 2022-12-19 (actual); primary completion 2025-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm
Acronym
RENOFIX
Condition
Aortic Aneurysm, Abdominal
Condition
Renal Insufficiency
Condition
Stent-Graft Thrombosis
Intervention (Device)
Stentgraft
Lead sponsor
Vastra Gotaland Region (class: other government)

Record details

Record id
cardio:ct-nct04754659
Content hash
b517b37ca4e5270ec1ae89f17cf43d8881343ed6fdd17ce4e0e6ef37e9fc0bf3